ADAMTSL5 and vitiligo: The authors suggested that patients with vitiligo and psoriasis are more prone to a combination of a Th17‐ and Th1‐skewed immune response, referring to the presence in psoriatic skin of memory CD8+ T cells directed against the melanocyte‐derived protein ADAMTSL5 that may favor the development of vitiligo in a predisposed patient.5